Varun Sriram 
Dealstreet

JSA assists Vizag Hospital and Cancer Research Centre on sale of shares

The enterprise value of the deal is ₹4,140 million.

Bar & Bench

Vizag Hospital and Cancer Research Centre Private Limited has proposed a sale of shares in Vizag Hospital to HealthCare Global Enterprises Limited for an Enterprise Value of ₹4,140 million.

The transaction is proposed to be completed in multiple tranches wherein HCG will acquire 51% of the equity share capital in Vizag Hospital in the first tranche and intends to complete the second tranche of acquisition of 34% of the equity share capital in the next 18 months.

The acquisition of the balance 15% of the equity share capital in Vizag Hospital may be pursuant to a time bound call option or put option.

JSA represented Vizag Hospital and Cancer Research Centre Private Limited and its shareholders on this transaction.

The transaction team consists of Varun Sriram (Lead Partner), Varsha Srinivasan (Principal Associate) and Nandini Menon V (Associate).

Vizag Hospital, owns and operates a comprehensive cancer care hospital in the city of Vishakhapatnam, Andhra Pradesh, with a well-built hospital infrastructure, led by Dr. Murali Krishna Voonna, a renowned onco-surgeon. The hospital boasts 196 operational beds and features advanced medical infrastructure.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Supreme Court refuses to stay Centre's decision to levy MDR on merchant UPI transactions over ₹2,000

No reason to doubt Speaker: Supreme Court dismisses plea for prompt decision on disqualification of rebel TMC MLAs

These are only by-elections: Supreme Court refuses to advance hearing of SIR case ahead of Nandigram, Rejinagar by-polls

Delhi High Court seeks response from Delhi Police on Sharjeel Imam's plea to access PhD study material in jail

Bombay High Court to hear plea against CEC Gyanesh Kumar on October 22, says no urgency

SCROLL FOR NEXT